1 option
Aripiprazole prolonged release suspension for injection (abilify maintena) (300 mg and 400 mg vial) / Canadian Agency for Drugs and Technologies in Health.
- Format:
- Book
- Author/Creator:
- Canadian Agency for Drugs and Technologies in Health, author, issuing body.
- Series:
- Common drug review clinical review report.
- Common drug review clinical review report
- Language:
- English
- Subjects (All):
- Outcome assessment (Medical care).
- Schizophrenia.
- Physical Description:
- 1 online resource : illustrations.
- Other Title:
- Aripiprazole prolonged release suspension for injection
- Place of Publication:
- Ottawa : Canadian Agency for Drugs and Technologies in Health, 2017.
- Notes:
- Description based on: online resource; title from PDF information screen (NCBI, viewed November 3, 2022).
- Includes bibliographical references.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.